PYC.AX
Price:
$2.04
Market Cap:
$1.19B
PYC Therapeutics Limited, a drug-development company, engages in the discovery and development of novel RNA therapeutics for the treatment of genetic diseases in Australia. The company offers VP-001, a drug program, which is in Phase 1 clinical trial for the treatment of retinitis pigmentosa type 11; PYC-001, a drug candidate for treating blinding eye disease named Autosomal Dominant Optic Atrophy, which is in clinical studies; PYC-002, a drug program for the treatment of severe neurodevelopmental disorder named Phelan-McDermid Syndrome, which is in pre-clinical studies; and PYC-003 to treat autosomal dominant polycystic kidney disease, which is in early-stage clinical trials. PYC Therapeuti...[Read more]
Industry
Biotechnology
IPO Date
2024-11-17
Stock Exchange
ASX
Ticker
PYC.AX
According to PYC Therapeutics Limited’s latest financial reports and current stock price. The company's current PE Ratio is -44.74. This represents a change of 46.26% compared to the average of -30.59 of the last 4 quarters.
The mean historical PE Ratio of PYC Therapeutics Limited over the last ten years is -203.25. The current -44.74 PE Ratio has changed 2.10% with respect to the historical average. Over the past ten years (40 quarters), PYC.AX's PE Ratio was at its highest in in the June 2025 quarter at -7.02. The PE Ratio was at its lowest in in the June 2006 quarter at -1550.00.
Average
-203.25
Median
-136.84
Minimum
-601.80
Maximum
-13.00
Discovering the peaks and valleys of PYC Therapeutics Limited PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 845.04%
Maximum Annual PE Ratio = -13.00
Minimum Annual Increase = -89.51%
Minimum Annual PE Ratio = -601.80
| Year | PE Ratio | Change |
|---|---|---|
| 2025 | -13.00 | -89.51% |
| 2024 | -123.96 | 56.44% |
| 2023 | -79.24 | -47.08% |
| 2022 | -149.72 | -44.58% |
| 2021 | -270.18 | -42.62% |
| 2020 | -470.83 | 157.46% |
| 2019 | -182.87 | 136.93% |
| 2018 | -77.18 | -87.17% |
| 2017 | -601.80 | 845.04% |
| 2016 | -63.68 | -59.14% |
The current PE Ratio of PYC Therapeutics Limited (PYC.AX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-72.07
5-year avg
-127.22
10-year avg
-203.25
PYC Therapeutics Limited’s PE Ratio is less than Clinuvel Pharmaceuticals Limited (14.52), less than Race Oncology Limited (-36.88), less than 4DMedical Limited (-13.05), less than Healius Limited (-0.56), less than Immutep Limited (-0.84), less than EBR Systems, Inc. (-2.09), less than Dimerix Limited (-10.11), less than Botanix Pharmaceuticals Limited (-0.49), less than Arovella Therapeutics Limited (-8.71), less than Orthocell Limited (-14.34),
| Company | PE Ratio | Market cap |
|---|---|---|
| 14.52 | $475.88M | |
| -36.88 | $391.16M | |
| -13.05 | $2.53B | |
| -0.56 | $304.99M | |
| -0.84 | $70.74M | |
| -2.09 | $124.47M | |
| -10.11 | $165.11M | |
| -0.49 | $45.83M | |
| -8.71 | $73.74M | |
| -14.34 | $198.80M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like PYC Therapeutics Limited using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like PYC Therapeutics Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is PYC Therapeutics Limited's PE Ratio?
How is the PE Ratio calculated for PYC Therapeutics Limited (PYC.AX)?
What is the highest PE Ratio for PYC Therapeutics Limited (PYC.AX)?
What is the 3-year average PE Ratio for PYC Therapeutics Limited (PYC.AX)?
What is the 5-year average PE Ratio for PYC Therapeutics Limited (PYC.AX)?
How does the current PE Ratio for PYC Therapeutics Limited (PYC.AX) compare to its historical average?